People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Other Health Care, Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Intrapace Inc | — | Other Health Care | Series D+ | $179.1M | $76.8M | 2010 |
| Rani Therapeutics, LLC | — | Biotechnology | Series C | $111.8M | $1.8B | 2015 |
| Spinal Modulation Inc | — | Other Health Care | Series C | $76.3M | $1.0B | 2013 |
| Rani Therapeutics Holdings, Inc. | — | Biotechnology | Series C | $60.3M | $326.1M | 2025 |
| Bodymedia Inc | — | Biotechnology | Series A | $20.1M | $429.9M | 2009 |
| InCube Crowdfunding, LLC | — | Other | Pre-Seed | $550K | $12.7M | 2013 |
Mir Imran at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mir Imran on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Dennis Ausiello | 2 | 4 |
| Andrew Farquharson | 2 | 4 |
| Svai Sanford | 2 | 2 |
| Talat Imran | 2 | 2 |
| Mir Hashim | 2 | 2 |
| Annette Campbell-White | 1 | 11 |
| TING PAU OEI | 1 | 7 |
| Eric Bell | 1 | 7 |
| J. Daniel Cole | 1 | 7 |
| Martin Dieck | 1 | 7 |
| Jay Katarincic | 1 | 6 |
| John Miclot | 1 | 5 |
| Richard M. Ferrari | 1 | 5 |
| V. Kadir Kadhiresan | 1 | 5 |
| Abraham Bassan | 1 | 4 |
| Richard Dantas | 1 | 2 |
| Jean-Luc Butel | 1 | 2 |
| David Kupfer | 1 | 2 |
| Wayne Roe | 1 | 2 |
| Eric Teller | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.